4.8 Review

The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

Yuan Fang et al.

Summary: This study showed that overexpression of MCT4 in HCC is associated with poor prognosis. Inhibition of MCT4 can suppress tumor growth, enhance immune cell infiltration and cytotoxicity. Furthermore, MCT4 inhibition can improve the therapeutic effect of anti-PD-1 immunotherapy and prolong survival in mice.

HEPATOLOGY (2023)

Review Immunology

Manipulation of metabolic pathways to promote stem-like and memory T cell phenotypes for immunotherapy

Michael D. D. Claiborne

Summary: Utilizing the immune system's capacity to recognize and kill tumor cells has revolutionized cancer therapy. Recent studies on antitumor T cells suggest that long-lived memory or stem-like cells have superior tumor control compared to terminally differentiated effector cells. This Mini-Review explores the profiling of metabolic programs that generate and define subsets of memory T cells. It also discusses experimental approaches to enhance the durability and sustained antitumor response of memory T cells in the immunosuppressive tumor microenvironment, including overcoming hypoxia-induced changes in mitochondrial function, inhibitory effects of tumor metabolites, and regulation of T cell memory fate through glycogen metabolism.

FRONTIERS IN IMMUNOLOGY (2023)

Review Oncology

Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer

Aleksandra Semeniuk-Wojtas et al.

Summary: Bladder cancer can be divided into non-muscle-invasive and muscle-invasive subgroups. The aggressiveness of the cancer is associated with genetic aberrations and metabolic disturbances. The current treatment options include transurethral resection with adjuvant therapy or radical cystectomy combined with chemotherapy. However, the efficacy of immunotherapy varies, and biomarkers are needed for proper treatment selection.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Article Medicine, Research & Experimental

CD8+and FoxP3+T-Cell Cellular Density and Spatial Distribution After Programmed Death-Ligand 1 Check Point Inhibition

Joseph Curry et al.

Summary: This study analyzed the cellular density and intercellular distances of CD8+ and FoxP3+ T-cells in head and neck squamous cell carcinoma samples. The results showed that the distribution of CD8+ and FoxP3+ cells was associated with treatment outcomes and pathological treatment response. Increased CD8+-FoxP3+ intercellular distances were closely related to pathological treatment response.

LARYNGOSCOPE (2023)

Review Immunology

Metabolism and epigenetics at the heart of T cell function

Leticia Soriano-Baguet et al.

Summary: T cell subsets adapt their metabolism to their functions and microenvironment, and changes in metabolism can affect T cell epigenetics. This review discusses the connections between T cell metabolism and epigenetic changes such as histone post-translational modifications and DNA methylation, as well as the non-metabolic roles of metabolic enzymes and molecules. These findings suggest potential therapeutic targets for T cell-dependent autoimmune diseases and cancers.

TRENDS IN IMMUNOLOGY (2023)

Article Immunology

T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing

Hao Chi et al.

Summary: A TEX-based signature was developed using single-cell RNA-seq and high-throughput RNA sequencing to evaluate the prognosis and immunotherapeutic response of HCC patients. The study found that TEX genes were closely associated with HCC prognosis, and patients in the low-risk group had a better overall survival rate. This study provides a new method for assessing immune therapy efficacy and has important implications for future precision immuno-oncology studies.

FRONTIERS IN IMMUNOLOGY (2023)

Article Cell Biology

Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer

Hannah N. Bell et al.

Summary: There is a lack of effective therapies for advanced colorectal cancer (CRC) patients. In the CRC tumor microenvironment, there is an accumulation of metabolic waste products, such as ammonia, due to altered metabolism and proximity to the microbiota. The role of metabolite waste in tumor development, progression, and treatment resistance is not well understood. This study demonstrates that high ammonia levels induce T cell metabolic reprogramming, leading to T cell exhaustion and decreased proliferation. Enhancing ammonia clearance can reactivate T cells and enhance the efficacy of immunotherapies.

CELL METABOLISM (2023)

Review Cell Biology

The hallmarks of cancer metabolism: Still emerging

Natalya N. Pavlova et al.

Summary: The metabolism of cancer cells is highly adaptable, allowing them to sustain growth and proliferation. This adaptation can also influence the behavior of non-transformed cells in the tumor vicinity.

CELL METABOLISM (2022)

Article Oncology

BCAT1: A risk factor in multiple cancers based on a pan-cancer analysis

Guo-Sheng Li et al.

Summary: This study comprehensively analyzes the expression, potential mechanisms, and clinical significance of BCAT1 in pan-cancer, revealing its differential expression in various cancers and its association with DNA methyltransferases expression, immune checkpoint inhibitors expression, microsatellite instability, and tumor mutational burden. The overexpression of BCAT1 is correlated with poor prognosis in cancer patients and has the potential to distinguish cancer tissues from normal tissues.

CANCER MEDICINE (2022)

Article Cell Biology

Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer

Sarah A. Best et al.

Summary: The tumor microenvironment in KRAS-mutant lung adenocarcinoma plays a crucial role in the activation of CD8 T cells, and the inhibition of glutaminase negatively impacts CD8 T cells activated by anti-PD1 immunotherapy.

CELL METABOLISM (2022)

Article Cell Biology

The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function

Mathias Wenes et al.

Summary: Mitochondrial pyruvate uptake instructs metabolic flexibility for guiding T cell differentiation and antitumor responses.

CELL METABOLISM (2022)

Article Cell Biology

A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy

Lupeng Ye et al.

Summary: This study developed a dgRNA-based CRISPR activation screen to identify gain-of-function (GOF) targets for CAR-T engineering. Enhancing PRODH2 expression improved the killing ability and in vivo efficacy of CAR-T cells against cancer. Metabolic and immunological analyses showed that PRODH2 engineering enhances the metabolic and immune functions of CAR-T cells.

CELL METABOLISM (2022)

Review Biochemistry & Molecular Biology

Lipid metabolism in T cell signaling and function

Seon Ah Lim et al.

Summary: T cells play a crucial role in immune response and can regulate the development of cancer and autoimmune diseases. Lipid metabolism is a key regulator of T cell function and fate decision, integrating environmental signals and intracellular signaling processes. This article discusses the roles of extracellular, de novo synthesized and membrane lipids in T cell biology, as well as their role as regulators of intracellular signaling. Therapeutic targeting of lipid metabolism and signaling is also summarized, with important future directions discussed.

NATURE CHEMICAL BIOLOGY (2022)

Review Immunology

Epigenetic regulation of T cell exhaustion

Julia A. Belk et al.

Summary: This review article examines the epigenetic underpinnings of T cell exhaustion during viral infections, cancer, autoimmunity, and T cell therapies. It discusses the technologies used to study the epigenome and highlights emerging multi-omic and genome engineering approaches for investigating T cell exhaustion and potential therapeutic opportunities.

NATURE IMMUNOLOGY (2022)

Article Oncology

Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy

Flor Navarro et al.

Summary: The acidification of the tumor microenvironment inhibits the activity of antitumor T cells. Inhibiting the acid loader Ae2 enhances T cell function, while silencing Ae2 or overexpressing Hvcn1 improves the antitumor activity of T cells.

ONCOIMMUNOLOGY (2022)

Review Medicine, Research & Experimental

Hypoxia, a key factor in the immune microenvironment

Jingyao Hu et al.

Summary: Hypoxia in the tumor microenvironment plays a crucial role in tumor development by regulating stromal elements, including immune cells. Targeting hypoxia can potentially prevent immune escape and inhibit malignant tumor progression.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Review Immunology

Manipulating T-cell metabolism to enhance immunotherapy in solid tumor

Chen Chen et al.

Summary: Cellular metabolism plays a critical role in tumor cells and T cells. Dysregulated metabolism is a hallmark of cancer and impacts the function of T cells. The interaction between tumor and T cell metabolism can affect T cell responses. Metabolic competition in the tumor ecosystem suppresses effector T cells. Targeting metabolic reprogramming shows promise in cancer treatment.

FRONTIERS IN IMMUNOLOGY (2022)

Article Cell Biology

Succinate uptake by T cells suppresses their effector function via inhibition of mitochondrial glucose oxidation

Nancy Gudgeon et al.

Summary: Tumor-associated succinate accumulation suppresses T cell function, including cytokine secretion, through inhibiting succinate uptake, succinyl coenzyme A synthetase activity, and glucose flux.

CELL REPORTS (2022)

Article Cell Biology

Carbon source availability drives nutrient utilization in CD8+ T cells

Irem Kaymak et al.

Summary: The impact of environmental nutrient availability on T cell metabolism and function is not well understood. This study found that physiologic carbon sources (PCSs) in cell culture medium have a broad impact on glucose utilization by CD8(+) T cells, independent of transcriptional changes in metabolic reprogramming. PCSs reduce glucose contribution to the TCA cycle and increase the effector function of CD8(+) T cells, with lactate directly contributing to the TCA cycle.

CELL METABOLISM (2022)

Article Oncology

Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

Emerson A. Lim et al.

Summary: The study evaluates the efficacy and safety of AZD4635 as monotherapy or in combination with durvalumab in patients with advanced solid tumors. The results demonstrate significant treatment responses in patients with metastatic castration-resistant prostate cancer receiving AZD4635 as monotherapy or in combination therapy.

CLINICAL CANCER RESEARCH (2022)

Article Multidisciplinary Sciences

Oncometabolite D-2HG alters T cell metabolism to impair CD8(+) T cell function

Giulia Notarangelo et al.

Summary: Gain-of-function mutations in IDH result in the production of oncometabolite D-2HG, which promotes tumorigenesis by affecting the metabolism and antitumor functions of CD8(+) T cells.

SCIENCE (2022)

Article Multidisciplinary Sciences

Lactate increases stemness of CD8+T cells to augment anti-tumor immunity

Qiang Feng et al.

Summary: Lactate increases stemness of CD8(+) T cells and enhances anti-tumor immunity. It inhibits histone deacetylase activity, leading to increased expression of Tcf7 gene, and affects the stemness of T cells.

NATURE COMMUNICATIONS (2022)

Review Immunology

Lipids for CD8+ TILs: Beneficial or harmful?

Duojiao Wu et al.

Summary: Lipids and lipid metabolism play important roles in regulating T cell function and immune memory. Tumor-infiltrating CD8(+) T lymphocytes restore their impaired function by burning fats, while fatty acids and cholesterol in the tumor microenvironment contribute to CD8(+) TILs dysfunction. Understanding the interplay between cellular lipid metabolism and CD8(+) TILs dysfunction is crucial for improving cancer immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity

Nina Dumauthioz et al.

Summary: The overexpression of PGC-1 alpha favors central memory formation of CD8 T cells and enhances antitumor immunity. CD8 T cells with enhanced PGC-1 alpha expression show stronger antitumor immunity in a melanoma model.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Cell Biology

Frontline Science: AMPK regulates metabolic reprogramming necessary for interferon production in human plasmacytoid dendritic cells

Harry J. Hurley et al.

Summary: The study indicates that AMP-activated protein kinase is a key driver of metabolic reprogramming in pDCs, with influenza activation leading to increased oxygen consumption and mitochondrial membrane potential, ultimately promoting IFN-alpha production.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Article Genetics & Heredity

The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer

Arafath K. Najumudeen et al.

Summary: Colorectal tumors with mutated KRAS and APC rely on the amino acid transporter SLC7A5 for tumorigenesis and enhanced protein synthesis. Targeting SLC7A5 could be an attractive approach for therapy-resistant KRAS-mutant colorectal cancer, as it plays a critical role in maintaining intracellular amino acid levels and supporting proliferation.

NATURE GENETICS (2021)

Article Immunology

Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion

Nicole E. Scharping et al.

Summary: Continuous TCR signaling and hypoxia increase Blimp-1, suppressing mitochondrial reprogramming and generating reactive oxygen species, leading to T cell exhaustion. Mitigating T cell-intrinsic ROS and reducing tumor hypoxia can limit T cell exhaustion, synergizing with immunotherapy.

NATURE IMMUNOLOGY (2021)

Article Immunology

MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects

Vivek Verma et al.

Summary: MEKi inhibition can induce CD8(+) T cell reprogramming into cells with stem cell-like memory characteristics, which exhibit stronger antitumor responses.

NATURE IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Counteracting CAR T cell dysfunction

Mansour Poorebrahim et al.

Summary: Despite the high rates of complete remission achieved through CAR T cell therapy, the efficacy of this approach is limited by dysfunctional CAR T cells, which can be improved through modifications to enhance antitumor functions and lifespan. Research is ongoing on blocking exhaustion and senescence in CAR T cells to boost potency in adoptive cell transfer therapies.

ONCOGENE (2021)

Review Biochemistry & Molecular Biology

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Xiaoqi Mao et al.

Summary: CAFs, as a crucial component of TME, play significant roles in promoting tumor growth, invasion, and metastasis. The interaction between CAFs and tumor cells, as well as immune cells in TIME, is critical for tumor progression.

MOLECULAR CANCER (2021)

Article Multidisciplinary Sciences

Metabolic support of tumour-infiltrating regulatory T cells by lactic acid

McLane J. Watson et al.

Summary: T-reg cells exhibit broad heterogeneity in glucose metabolism within normal and transformed tissues, utilizing an alternative metabolic pathway to maintain their suppressive function and proliferation. Glucose uptake is correlated with poorer suppressive function and long-term instability, while high-glucose conditions impair T-reg cell function and stability. Additionally, T-reg cells upregulate pathways involved in the metabolism of lactic acid, with lactate uptake being dispensable for peripheral T-reg cells but required intratumorally for slowed tumor growth and increased response to immunotherapy.

NATURE (2021)

Article Oncology

Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy

Robert D. Leone et al.

Summary: The success of immune-based therapies for cancer has highlighted the critical role of metabolic programs specific to immune cell type and function. Understanding the metabolic requirements of immune cells in the tumor microenvironment can significantly improve the efficacy of cancer immunotherapy.

CANCER IMMUNOLOGY RESEARCH (2021)

Article Cell Biology

Regulatory T cell differentiation is controlled by αKG-induced alterations in mitochondrial metabolism and lipid homeostasis

Maria Matias et al.

Summary: It is demonstrated that aKG alters DNA methylation profile of CD4 T cells, inhibits Treg differentiation, and promotes inflammatory cytokine expression, leading to enhanced tumor infiltration. aKG shifts cellular energy state towards mitochondrial metabolism and directly participates in fatty acid synthesis.

CELL REPORTS (2021)

Article Immunology

Kdm6b Regulates the Generation of Effector CD8+ T Cells by Inducing Chromatin Accessibility in Effector-Associated Genes

Tianhao Xu et al.

Summary: Kdm6b is essential for the proper generation and function of effector CD8(+) T cells, with its deficiency impacting effector cell generation and function, as well as recall response of memory CD8(+) T cells. The study suggests Kdm6b as a potential therapeutic target for diseases with dysregulated effector responses by regulating chromatin accessibility in effector-associated genes.

JOURNAL OF IMMUNOLOGY (2021)

Article Oncology

Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer

Jones Gyamfi et al.

Summary: Adipocytes influence breast cancer behavior by releasing fatty acids into the tumor microenvironment. CD36 serves as a key mediator in the import and metabolism of fatty acids in cancer cells, interacting with STAT3 to drive tumor progression. Inhibition of CD36 and FABP4 induces apoptosis in tumor cells, indicating their potential as therapeutic targets in the tumor microenvironment.

NPJ BREAST CANCER (2021)

Editorial Material Multidisciplinary Sciences

Metabolic plasticity allows cancer cells to thrive under nutrient starvation

Wilhelm Palm

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Oncology

CAR-T cell therapy: current limitations and potential strategies

Robert C. Sterner et al.

Summary: CAR-T cell therapy has shown remarkable clinical responses in certain subsets of leukemia or lymphoma, but faces challenges in solid tumors and hematological malignancies. Innovative strategies and approaches are necessary to overcome these challenges and improve the efficacy of CAR-T cells.

BLOOD CANCER JOURNAL (2021)

Review Oncology

The complex Integration of T-cell Metabolism and Immunotherapy

Matthew Z. Madden et al.

Summary: The metabolic reprogramming of T cells plays a crucial role in their function and fate, but is disrupted in cancer, potentially suppressing antitumor immunity. Therefore, stimulating effector T cell metabolism and enhancing cancer immunotherapy are challenges and opportunities that need to be addressed.

CANCER DISCOVERY (2021)

Article Immunology

IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation

Adaobi Amobi-McCloud et al.

Summary: The study reveals the connection between IDO1 and AHR pathways with PD-1 expression and T cell infiltration in ovarian cancer, by affecting the tumor microenvironment through regulating tryptophan metabolic pathways. These findings facilitate the design of strategies to enhance anti-tumor immunity in ovarian cancer.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy

Guillermo O. Rangel Rivera et al.

Summary: The review discusses how targeting metabolic pathways can enhance the immune response of T cells to tumors, as tumors consume key metabolites in the host, depriving T cells of essential nutrients for growth and function. Furthermore, immunosuppressive molecules and checkpoint receptors further compromise the activity of T cells within tumors.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors

Shihao Xu et al.

Summary: The accumulation of lipids in the tumor microenvironment is associated with dysfunction of CD8(+) T cells, mediated in part by the CD36 receptor and its promotion of lipid uptake and peroxidation. Inhibiting p38 kinase or resolving lipid peroxidation may restore effector T cell functions and provide a potential therapeutic avenue for immunotherapies.

IMMUNITY (2021)

Editorial Material Cell Biology

Polyamines instruct T-cell differentiation

Jie Wang

NATURE CELL BIOLOGY (2021)

Review Immunology

Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer

Violet Y. Tu et al.

Summary: The metabolic characteristics of the tumor microenvironment play a crucial role in the effectiveness of T cell therapies, with lactate and other metabolic factors potentially suppressing the ability of antigen-specific T cells to eradicate tumors. Targeting the TME may offer new opportunities to enhance T cell-based therapies against cancer.

ANTIBODIES (2021)

Review Oncology

Cancer metabolism: looking forward

Inmaculada Martinez-Reyes et al.

Summary: This Perspective discusses the main themes in cancer metabolism research, focusing on the relationship between tumour initiation and progression with metabolic reprogramming, as well as the importance of tumor microenvironment and metabolic regulation.

NATURE REVIEWS CANCER (2021)

Review Biochemistry & Molecular Biology

Amino acids in cancer

Elizabeth L. Lieu et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Review Geriatrics & Gerontology

Kynurenine signaling through the aryl hydrocarbon receptor: Implications for aging and healthspan

Helen Kaiser et al.

EXPERIMENTAL GERONTOLOGY (2020)

Review Urology & Nephrology

Competitive glucose metabolism as a target to boost bladder cancer immunotherapy

Julieta Afonso et al.

NATURE REVIEWS UROLOGY (2020)

Article Medicine, Research & Experimental

Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells

Min-Hee Oh et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Multidisciplinary Sciences

Cancer SLC43A2 alters T cell methionine metabolism and histone methylation

Yingjie Bian et al.

NATURE (2020)

Article Immunology

Disturbed mitochondrial dynamics in CD8+TILs reinforce T cell exhaustion

Yi-Ru Yu et al.

NATURE IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design

Saba Ghassemi et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Review Oncology

The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives

Wenjun Wang et al.

FRONTIERS IN ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity

Joy X. Wang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Endocrinology & Metabolism

Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy

Ramon I. Klein Geltink et al.

NATURE METABOLISM (2020)

Review Oncology

Metabolism of immune cells in cancer

Robert D. Leone et al.

NATURE REVIEWS CANCER (2020)

Article Cell Biology

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

Xingzhe Ma et al.

CELL METABOLISM (2019)

Review Biochemistry & Molecular Biology

Reactive oxygen species: a volatile driver of field cancerization and metastasis

Zehuan Liao et al.

MOLECULAR CANCER (2019)

Article Cell Biology

Acetate Promotes T Cell Effector Function during Glucose Restriction

Jing Qiu et al.

CELL REPORTS (2019)

Review Immunology

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function

Selena Vigano et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Oncology

Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer

Asmaa El-Kenawi et al.

BRITISH JOURNAL OF CANCER (2019)

Review Cell Biology

Mechanisms and Implications of Metabolic Heterogeneity in Cancer

Jiyeon Kim et al.

CELL METABOLISM (2019)

Article Multidisciplinary Sciences

Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

Robert D. Leone et al.

SCIENCE (2019)

Review Immunology

Fatty acid metabolism in CD8+ T cell memory: Challenging current concepts

Brenda Raud et al.

IMMUNOLOGICAL REVIEWS (2018)

Review Medicine, General & Internal

Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma

Yucheng Fu et al.

MEDICINE (2018)

Review Immunology

Targeting Tumor Metabolism: A New Challenge to improve immunotherapy

Soumaya Kouidhi et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Oncology

Targeting adenosine for cancer immunotherapy

Robert D. Leone et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

Review Oncology

Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy

Thibault Le Bourgeois et al.

FRONTIERS IN ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism

Marc O. Johnson et al.

Review Immunology

CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy

Monika C. Brunner-Weinzierl et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Immunology

Unraveling the Complex Interplay Between T Cell Metabolism and Function

Ramon I. Klein Geltink et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)

Review Biochemistry & Molecular Biology

Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer

S. Chouaib et al.

ONCOGENE (2017)

Review Immunology

Biochemical Underpinnings of Immune Cell Metabolic Phenotypes

Benjamin A. Olenchock et al.

IMMUNITY (2017)

Review Immunology

The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets

Bertrand Allard et al.

IMMUNOLOGICAL REVIEWS (2017)

Review Cell Biology

Targeting A2 adenosine receptors in cancer

David Allard et al.

IMMUNOLOGY AND CELL BIOLOGY (2017)

Editorial Material Immunology

M1 Means Kill; M2 Means Heal

Klaus Ley

JOURNAL OF IMMUNOLOGY (2017)

Review Biochemistry & Molecular Biology

ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway

Yang Zhao et al.

MOLECULAR CANCER (2017)

Review Immunology

The role of AMPK in T cell metabolism and function

Eric H. Ma et al.

CURRENT OPINION IN IMMUNOLOGY (2017)

Review Biochemistry & Molecular Biology

Dysfunctional T cell metabolism in the tumor microenvironment

Kathryn E. Beckermann et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2017)

Article Oncology

Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy

Shari Pilon-Thomas et al.

CANCER RESEARCH (2016)

Review Oncology

The Role of Cholesterol in Cancer

Omer F. Kuzu et al.

CANCER RESEARCH (2016)

Article Biochemistry & Molecular Biology

Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche

David Clever et al.

Article Biochemistry & Molecular Biology

L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity

Roger Geiger et al.

Editorial Material Cell Biology

Lactate Wreaks Havoc on Tumor-Infiltrating T and NK Cells

Kristen E. N. Scott et al.

Cell Metabolism (2016)

Review Cell Biology

The Emerging Hallmarks of Cancer Metabolism

Natalya N. Pavlova et al.

CELL METABOLISM (2016)

Article Multidisciplinary Sciences

Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion

Cristovao M. Sousa et al.

NATURE (2016)

Article Multidisciplinary Sciences

S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate

Petros A. Tyrakis et al.

NATURE (2016)

Article Multidisciplinary Sciences

Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers

Edouard Mullarky et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Multidisciplinary Sciences

Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers

Jared R. Mayers et al.

SCIENCE (2016)

Review Biochemistry & Molecular Biology

The Warburg Effect: How Does it Benefit Cancer Cells?

Maria V. Liberti et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Review Immunology

T Cells and Cancer: How Metabolism Shapes Immunity

Barbara Molon et al.

FRONTIERS IN IMMUNOLOGY (2016)

Article Oncology

Targeting CD73 in the tumor microenvironment with MEDI9447

Carl M. Hay et al.

ONCOIMMUNOLOGY (2016)

Review Multidisciplinary Sciences

Fundamentals of cancer metabolism

Ralph J. DeBerardinis et al.

SCIENCE ADVANCES (2016)

Review Immunology

Purinergic regulation of the immune system

Caglar Cekic et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Review Oncology

Novel drugs that target the metabolic reprogramming in renal cell cancer

Johannes C. van der Mijn et al.

CANCER & METABOLISM (2016)

Article Nutrition & Dietetics

Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond

Elitsa A. Ananieva et al.

ADVANCES IN NUTRITION (2016)

Article Biochemistry & Molecular Biology

Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses

Ping-Chih Ho et al.

Article Biochemistry & Molecular Biology

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

Chih-Hao Chang et al.

Article Oncology

Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer

Mohamed Hassanein et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Review Immunology

T cell metabolism drives immunity

Michael D. Buck et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Article Medicine, Research & Experimental

Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer

Li-Ying OuYang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2015)

Article Biochemistry & Molecular Biology

Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K

Rupert Courtnay et al.

MOLECULAR BIOLOGY REPORTS (2015)

Editorial Material Biochemistry & Molecular Biology

Cancer Cells Hijack Gluconeogenic Enzymes to Fuel Cell Growth

Eduardo Balsa-Martinez et al.

MOLECULAR CELL (2015)

Article Multidisciplinary Sciences

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation

Nikolaos Patsoukis et al.

NATURE COMMUNICATIONS (2015)

Review Immunology

Tryptophan-degrading enzymes in tumoral immune resistance

Nicolas van Baren et al.

FRONTIERS IN IMMUNOLOGY (2015)

Article Multidisciplinary Sciences

RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity

Brandon L. Probst et al.

PLOS ONE (2015)

Review Immunology

Molecular and cellular insights into T cell exhaustion

E. John Wherry et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Oncology

A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells

Ivraym B. Barsoum et al.

CANCER RESEARCH (2014)

Article Biochemistry & Molecular Biology

Acetate Dependence of Tumors

Sarah A. Comerford et al.

Editorial Material Biochemistry & Molecular Biology

Acetate Fuels the Cancer Engine

Costas A. Lyssiotis et al.

Article Oncology

Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer

Radoslaw Polanski et al.

CLINICAL CANCER RESEARCH (2014)

Article Biochemistry & Molecular Biology

Metabolic Reprogramming of Macrophages GLUCOSE TRANSPORTER 1 (GLUT1)-MEDIATED GLUCOSE METABOLISM DRIVES A PROINFLAMMATORY PHENOTYPE

Alex J. Freemerman et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma

Hala Girgis et al.

MOLECULAR CANCER (2014)

Article Oncology

Polyamine-Blocking Therapy Reverses Immunosuppression in the Tumor Microenvironment

Candace S. Hayes et al.

CANCER IMMUNOLOGY RESEARCH (2014)

Review Biochemistry & Molecular Biology

How does the metabolism of tumour cells differ from that of normal cells

Nivea Dias Amoedo et al.

BIOSCIENCE REPORTS (2013)

Article Oncology

Acidity Generated by the Tumor Microenvironment Drives Local Invasion

Veronica Estrella et al.

CANCER RESEARCH (2013)

Article Biochemistry & Molecular Biology

Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis

Chih-Hao Chang et al.

Article Medicine, Research & Experimental

Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function

Madhusudhanan Sukumar et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Biochemistry & Molecular Biology

Tumor glycolysis as a target for cancer therapy: progress and prospects

Shanmugasundaram Ganapathy-Kanniappan et al.

MOLECULAR CANCER (2013)

Article Multidisciplinary Sciences

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway

Jaekyoung Son et al.

NATURE (2013)

Article Biochemistry & Molecular Biology

BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1

Martje Toenjes et al.

NATURE MEDICINE (2013)

Review Pharmacology & Pharmacy

Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth, Angiogenesis and Metastasis

Suveera Dhup et al.

CURRENT PHARMACEUTICAL DESIGN (2012)

Review Cell Biology

Links between metabolism and cancer

Chi V. Dang

GENES & DEVELOPMENT (2012)

Review Immunology

mTOR, metabolism, and the regulation of T-cell differentiation and function

Adam T. Waickman et al.

IMMUNOLOGICAL REVIEWS (2012)

Review Immunology

Metabolic switching and fuel choice during T-cell differentiation and memory development

Gerritje J. W. van der Windt et al.

IMMUNOLOGICAL REVIEWS (2012)

Article Oncology

Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation

Anna N. Mendler et al.

INTERNATIONAL JOURNAL OF CANCER (2012)

Review Immunology

Metabolic pathways in T cell fate and function

Valerie A. Gerriets et al.

TRENDS IN IMMUNOLOGY (2012)

Review Oncology

Cancer Cell Metabolism: One Hallmark, Many Faces

Jason R. Cantor et al.

CANCER DISCOVERY (2012)

Review Oncology

Lactate: A Metabolic Key Player in Cancer

Franziska Hirschhaeuser et al.

CANCER RESEARCH (2011)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Multidisciplinary Sciences

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

Andrea Facciabene et al.

NATURE (2011)

Article Biochemistry & Molecular Biology

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

Vinod P. Balachandran et al.

NATURE MEDICINE (2011)

Review Oncology

Otto Warburg's contributions to current concepts of cancer metabolism

Willem H. Koppenol et al.

NATURE REVIEWS CANCER (2011)

Review Biochemistry & Molecular Biology

Reactive oxygen species in cancer

Geou-Yarh Liou et al.

FREE RADICAL RESEARCH (2010)

Review Immunology

The metabolic life and times of a T-cell

Ryan D. Michalek et al.

IMMUNOLOGICAL REVIEWS (2010)

Article Multidisciplinary Sciences

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

John Stagg et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

Enhancing CD8 T-cell memory by modulating fatty acid metabolism

Erika L. Pearce et al.

NATURE (2009)

Review Oncology

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

Javier A. Menendez et al.

NATURE REVIEWS CANCER (2007)

Review Oncology

Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues

D. Lukashev et al.

CANCER AND METASTASIS REVIEWS (2007)

Article Hematology

L-arginine availability regulates T-lymphocyte cell-cycle progression

Paulo C. Rodriguez et al.

BLOOD (2007)

Review Immunology

Fuel feeds function: Energy metabolism and the T-cell response

CJ Fox et al.

NATURE REVIEWS IMMUNOLOGY (2005)

Review Immunology

Regulation of immune responses by L- arginine metabolism

V Bronte et al.

NATURE REVIEWS IMMUNOLOGY (2005)

Article Biochemistry & Molecular Biology

Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans

N Gupta et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)

Article Immunology

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers

V Bronte et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Article Multidisciplinary Sciences

Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination

C De Santo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)